STOCK TITAN

US Global Investors Inc (GROW) Financials

GROW
FY2026 annual
Revenue $14.4M +32.8% YoY
Net Income $3.1M +1014.7% YoY
EPS (Diluted) $0.24 +900.0% YoY
Free Cash Flow $682K +182.3% YoY
Market Cap $35.2M as of Oct 14, 2026
Price / Sales 2.4x on $14.4M revenue, FY2026
Price / Earnings 11.5x on $3.1M net income, FY2026
Price / Book 0.8x on $45.1M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Sep 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GROW SEC filings page.

US Global Investors Inc (GROW) reported $14.4M in revenue for fiscal year 2026, up 32.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GROW FY2026

FY2026 restored net profitability, but core operations still lost money and generated only modest cash.

FY2026 net income of $3.1M arrived despite an operating loss of $603K; below-operating-line items materially changed the reported result. Operating cash flow was only $742K, so the earnings reversal from FY2025's net loss of $334K did not translate proportionally into cash.

The balance sheet is financed overwhelmingly by equity: FY2026 liabilities were $2.9M against $48.0M of assets, while debt-to-equity was 0.1x. That structure limits the role of borrowing in the business model rather than amplifying results through leverage.

Revenue recovered 32.8% in FY2026, while gross margin reached 24.9% after being negative in FY2025. Yet operating margin remained -4.2%, indicating the restored gross profit still did not cover the full operating cost base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 54 / 100
Financial Health Score 54/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of US Global Investors Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
15

US Global Investors Inc has an operating margin of -4.2%, meaning the company loses $4 on every $100 of revenue. This results in a profitability score of 15/100. This is up from -27.5% the prior year.

Growth
74

US Global Investors Inc's revenue surged 32.8% year-over-year to $14.4M, reflecting rapid business expansion. This strong growth earns a score of 74/100.

Leverage
83

US Global Investors Inc carries a low D/E ratio of 0.06, meaning only $0.06 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 83/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
99

With a current ratio of 19.71, US Global Investors Inc holds $19.71 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 99/100.

Cash Flow
30

US Global Investors Inc has a free cash flow margin of 4.7%, earning a moderate score of 30/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
22

US Global Investors Inc generates a 6.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is up from -0.7% the prior year.

Altman Z-Score Safe
9.54

US Global Investors Inc scores 9.54, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($35.2M) relative to total liabilities ($2.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
5/7

US Global Investors Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Low Quality
0.24x

For every $1 of reported earnings, US Global Investors Inc generates $0.24 in operating cash flow ($742K OCF vs $3.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
N/A

US Global Investors Inc reported an operating loss of $603K against $6K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.9M
YoY+57.9%
QoQ+149.0%
5Y CAGR-1.3%

US Global Investors Inc generated $6.9M in revenue in Q4 2026. This represents an increase of 57.9% from the same quarter a year earlier. Against the prior quarter it is up 149.0%.

EBITDA
-$78K
YoY+92.1%
QoQ-179.6%

US Global Investors Inc's EBITDA was -$78K in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 92.1% from the same quarter a year earlier. Against the prior quarter it is down 179.6%.

Net Income
-$283K
YoY-56.4%
QoQ-110.6%

US Global Investors Inc reported -$283K in net income in Q4 2026. This represents a decrease of 56.4% from the same quarter a year earlier. Against the prior quarter it is down 110.6%.

EPS (Diluted)
-$0.02
QoQ-109.5%

US Global Investors Inc earned -$0.02 per diluted share (EPS) in Q4 2026. Against the prior quarter it is down 109.5%.

Cash & Balance Sheet

Free Cash Flow
$203K
YoY+1453.3%
QoQ-26.2%

US Global Investors Inc generated $203K in free cash flow in Q4 2026, representing cash available after capex. This represents an increase of 1453.3% from the same quarter a year earlier. Against the prior quarter it is down 26.2%.

Cash & Debt
$24.3M
YoY-0.9%
QoQ-1.0%
5Y CAGR+11.0%
10Y CAGR+19.8%

US Global Investors Inc held $24.3M in cash as of Q4 2026; long-term debt is not reported for that period.

Dividends Per Share
$0.00

US Global Investors Inc paid $0.00 per share in dividends in Q4 2026.

Shares Outstanding

Not reported for Q4 2026.

Margins & Returns

Operating Margin
-1.3%
YoY+21.6pp
QoQ-4.5pp
5Y change-53.9pp

US Global Investors Inc's operating margin was -1.3% in Q4 2026, reflecting core business profitability. This is up 21.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.

Net Margin
-4.1%
YoY0.0pp
QoQ-101.0pp
5Y change-68.9pp

US Global Investors Inc's net profit margin was -4.1% in Q4 2026, showing the share of revenue converted to profit. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 101.0 percentage points.

Return on Equity
-0.6%
YoY-0.2pp
QoQ-6.4pp
5Y change-9.4pp
10Y change+0.4pp

US Global Investors Inc's ROE was -0.6% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.4 percentage points.

Gross Margin

Not reported for Q4 2026.

Capital Allocation

Share Buybacks
$364K
YoY-7.8%
QoQ-34.1%
5Y CAGR+23.8%
10Y CAGR+23.5%

US Global Investors Inc spent $364K on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 7.8% from the same quarter a year earlier. Against the prior quarter it is down 34.1%.

Capital Expenditures
$20K
YoY+1900.0%
QoQ0.0%

US Global Investors Inc invested $20K in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 1900.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

R&D Spending

Not reported for Q4 2026.

GROW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GROW quarterly income statement
MetricQ4'2610-KQ3'2610-Q/AQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q/AQ2'2510-QQ1'2510-Q
Revenue$6.9M+57.9%$2.8M+31.3%$2.5M+12.5%$2.3M+4.4%$4.4M+78.4%$2.1M-18.9%$2.2M-20.8%$2.2M-31.2%
SG&A Expenses$1.3M-7.7%$1.4M-2.9%$1.2M-14.9%$1.4M-6.2%$1.4M+8.4%$1.5M-16.2%$1.4M-6.5%$1.5M+0.1%
Operating Income-$88K+91.2%$88K+109.9%-$88K+83.7%-$515K+7.9%-$995K-149.4%-$893K-83.0%-$539K-380.7%-$559K-360.0%
EBITDA-$78K+92.1%$98K+111.1%-$77K+85.3%-$504K+6.1%-$983K-167.8%-$882K-97.3%-$523K-305.9%-$537K-294.6%
Interest Expense$0$2K$2K$2K+100.0%$0-100.0%$0-100.0%$0$1K0.0%
Income Tax-$45K+71.2%-$844K-716.1%$1.4M+4703.3%$337K+178.5%-$156K-214.7%$137K+82.7%-$30K-106.9%$121K+286.2%
Net Income-$283K-56.4%$2.7M+800.8%-$846K-883.7%$1.5M+378.4%-$181K-157.5%-$382K-991.4%-$86K-107.0%$315K+279.0%
EPS (Basic)-$0.020.0%$0.21+800.0%-$0.07-600.0%$0.12+500.0%-$0.02-200.0%-$0.03-$0.01-111.1%$0.02+300.0%
EPS (Diluted)-$0.02$0.21+800.0%-$0.07-600.0%$0.12+500.0%-$0.02-$0.03-$0.01$0.02+300.0%
Diluted Shares (Avg)N/A13M-3.4%13M-5.4%13M-5.4%N/A13M-7.5%13M14M-5.2%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

GROW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GROW quarterly balance sheet
MetricQ4'2610-KQ3'2610-Q/AQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q/AQ2'2510-QQ1'2510-Q
Total Assets$48.0M-0.1%$48.9M+0.3%$47.2M-5.8%$48.9M-4.2%$48.1M-7.5%$48.8M-7.6%$50.1M-6.6%$51.1M-5.6%
Current Assets$37.6M-3.9%$38.1M-3.2%$38.7M-3.3%$39.1M-2.6%$39.1M-3.0%$39.3M-4.0%$40.0M-1.1%$40.1M-0.9%
Cash & Equivalents$24.3M-0.9%$24.6M-6.4%$25.2M-3.1%$24.6M-10.1%$24.6M-10.4%$26.3M-4.4%$26.0M-5.2%$27.3M+1.8%
Short-Term Investments$8.9M-8.5%$9.2M-5.1%$9.2M-4.7%$9.7M+0.2%$9.7M+0.5%$9.7M-3.8%$9.7M-4.2%$9.7M-10.0%
Long-Term Investments$2.9M+15.1%$3.2M+146.5%$3.7M+189.4%$3.0M+109.2%$2.5M+72.3%$1.3M-8.6%$1.3M-12.7%$1.5M-77.1%
Total Liabilities$2.9M+1.3%$2.9M+8.1%$3.0M+8.0%$2.9M+8.2%$2.9M-3.4%$2.7M-9.2%$2.8M+3.0%$2.7M-19.9%
Current Liabilities$1.9M+1.8%$1.8M+0.4%$2.0M-0.5%$1.9M-0.5%$1.9M-13.4%$1.8M-22.6%$2.0M-7.1%$1.9M-32.3%
Non-Current Liabilities$988K+0.5%$1.1M+24.5%$1.1M+28.8%$1.0M+28.8%$983K+24.0%$846K+44.6%$822K+39.6%$802K+42.5%
Total Equity$45.1M-0.2%$46.0M-0.1%$44.2M-6.6%$46.0M-4.9%$45.2M-7.8%$46.1M-7.2%$47.3M-6.8%$48.4M-4.3%
Retained Earnings$37.9M+5.4%$38.4M+5.5%$36.0M-2.9%$37.2M-0.8%$35.9M-4.1%$36.4M-3.2%$37.1M-2.3%$37.5M+1.1%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

GROW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GROW quarterly cash flow statement
MetricQ4'2610-KQ3'2610-Q/AQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q/AQ2'2510-QQ1'2510-Q
Operating Cash Flow$223K+1692.9%$295K+169.4%$256K+164.2%-$32K-300.0%-$14K-110.2%-$425K-645.6%-$399K-1634.6%$16K-98.2%
Depreciation & Amortization$10K-9.1%$10K-9.1%$11K-31.3%$11K-50.0%$11K-66.7%$11K-73.2%$16K-74.2%$22K-63.9%
Stock-Based CompensationN/A$0-100.0%$0-100.0%$9KN/A$58K$11K$0
Capital Expenditures$20K+1900.0%$20K+1900.0%N/AN/A$1K-97.1%-$1K-98.5%$7K-86.5%$0-100.0%
Free Cash Flow$203K+1453.3%$275K+164.6%N/AN/A-$15K-114.6%-$426K-240.8%-$406K-1461.5%$16K-98.1%
Investing Cash Flow$164K+115.3%-$124K-108.9%$1.3M+11316.7%$738K-1.6%-$1.1M-302.1%$1.4M+48.4%-$12K-100.8%$750K-49.7%
Financing Cash Flow-$632K-0.8%-$823K-11.1%-$961K-8.6%-$672K+18.9%-$627K+13.8%-$741K+16.2%-$885K-1.4%-$829K+10.6%
Dividends Paid$279K-5.7%$283K-5.4%$287K-5.9%$292K-5.2%$296K-5.4%$299K-5.7%$305K-5.3%$308K-5.5%
Share Buybacks$364K-7.8%$552K+21.9%$666K+12.7%$390K-26.4%$395K-6.8%$453K-21.5%$591K+5.5%$530K-13.3%

GROW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GROW quarterly financial ratios
MetricQ4'2610-KQ3'2610-Q/AQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-Q/AQ2'2510-QQ1'2510-Q
Operating Margin-1.3%+21.6pp3.2%+45.6pp-3.5%+20.7pp-22.9%+3.0pp-22.9%-6.5pp-42.5%-23.6pp-24.2%-31.0pp-25.9%-32.8pp
Net Margin-4.1%0.0pp96.9%+115.1pp-33.7%-29.9pp67.0%+52.3pp-4.2%-17.1pp-18.2%-16.8pp-3.9%-47.5pp14.6%+20.2pp
Return on Equity-0.6%-0.2pp5.8%+6.6pp-1.9%-1.7pp3.3%+2.6pp-0.4%-1.0pp-0.8%-0.8pp-0.2%-2.6pp0.7%+1.0pp
Return on Assets-0.6%-0.2pp5.5%+6.3pp-1.8%-1.6pp3.1%+2.5pp-0.4%-1.0pp-0.8%-0.7pp-0.2%-2.5pp0.6%+0.9pp
Current Ratio19.71-1.2x20.91-0.8x19.42-0.6x20.51-0.4x20.87+2.2x21.69+4.2x19.98+1.2x20.96+6.6x
Debt-to-Equity0.060.0x0.060.0x0.070.0x0.060.0x0.060.0x0.060.0x0.060.0x0.060.0x
Asset Turnover0.14+0.1x0.060.0x0.050.0x0.050.0x0.090.0x0.040.0x0.040.0x0.040.0x
FCF Margin2.9%+3.3pp10.0%+30.2ppN/AN/A-0.3%-4.6pp-20.3%-15.4pp-18.2%-17.3pp0.7%-25.6pp

Not reported in any period shown, so not listed: Gross Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
US Global Investors Inc GROW FY2026 $14.4M $3.1M 21.2% $35.2M 54/100
Equus Total Return, Inc. EQS FY2025 N/A -$14.2M N/A $11.7M —
Binah Capital Group, Inc. BCG FY2025 $187.1M $2.3M 1.2% $17.4M 18/100
Royalty Management Holding Corporation RMCO FY2025 $4.9M -$727K -14.7% $37.5M 58/100
Rand Capital Corp RAND FY2025 N/A -$8.0M N/A $28.5M —

Frequently Asked Questions

What is US Global Investors Inc's annual revenue?

US Global Investors Inc (GROW) reported $14.4M in total revenue for fiscal year 2026. This represents a 32.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is US Global Investors Inc's revenue growing?

US Global Investors Inc (GROW) revenue grew by 32.8% year-over-year, from $10.8M to $14.4M in fiscal year 2026.

Is US Global Investors Inc profitable?

Yes, US Global Investors Inc (GROW) reported a net income of $3.1M in fiscal year 2026, with a net profit margin of 21.2%.

US Global Investors Inc (GROW) reported diluted earnings per share of $0.24 for fiscal year 2026. This represents a 900.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

US Global Investors Inc (GROW) had EBITDA of -$561K in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

US Global Investors Inc (GROW) had a gross margin of 24.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

US Global Investors Inc (GROW) had an operating margin of -4.2% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

US Global Investors Inc (GROW) had a net profit margin of 21.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Yes, US Global Investors Inc (GROW) paid $0.01 per share in dividends during fiscal year 2026.

US Global Investors Inc (GROW) has a return on equity of 6.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

US Global Investors Inc (GROW) generated $682K in free cash flow during fiscal year 2026. This represents a 182.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

US Global Investors Inc (GROW) generated $742K in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

US Global Investors Inc (GROW) had $48.0M in total assets as of fiscal year 2026, including both current and long-term assets.

US Global Investors Inc (GROW) invested $60K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, US Global Investors Inc (GROW) spent $2.0M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

US Global Investors Inc (GROW) had a current ratio of 19.71 as of fiscal year 2026, which is generally considered healthy.

US Global Investors Inc (GROW) had a debt-to-equity ratio of 0.06 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

US Global Investors Inc (GROW) had a return on assets of 6.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

US Global Investors Inc (GROW) trades at 11.5x earnings, its market capitalization divided by net income of $3.1M net income, FY2026. The market capitalization is $35.2M as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

US Global Investors Inc (GROW) trades at 2.4x sales, its market capitalization divided by revenue of $14.4M revenue, FY2026. The market capitalization is $35.2M as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

US Global Investors Inc (GROW) has an Altman Z-Score of 9.54, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

US Global Investors Inc (GROW) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

US Global Investors Inc (GROW) has an earnings quality ratio of 0.24x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

US Global Investors Inc (GROW) reported an operating loss of $603K against $6K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

US Global Investors Inc (GROW) scores 54 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top